Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_999_Библиотеки_им_академика_М_И_Перельмана
.pdf
152
https://t.me/med1917
M. Wobith and A. Weimann
References
1. Williams DGA, Molinger J, Wischmeyer PE.The malnourished surgery patient: a silent epidemic in perioperative outcome? Curr Opin Anesthesiol. 2019;32:405–11.
2. Simonsen C, de Heer P, Bjerre ED, Suetta C, Hojman P, Pedersen BK, Svendsen LB,
Christensen JF. Sarcopenia and postoperative complication risk in gastrointestinal surgical
oncology: a meta-analysis. Ann Surg. 2018;268:58–69.
3. Cao Y, Han D, Zhou X, Han Y, Zhang Y, Li H.Effects of preoperative nutrition on postoperative outcomes in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus.
2022;35(3):doab028.
4. Kenny E, Samavat H, Touger-Decker R, Parrott JS, Byham-Gray L, August DA.Adverse perioperative outcomes among patients undergoing gastrointestinal cancer surgery: quantifying
attributable risk from malnutrition. JPEN J Parenter Enteral Nutr. 2022;46(3):517–25.
5. Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, Laviano A, Ljungqvist
O, Lobo DN, Martindale R, Waitzberg DL, Bischoff SC, Singer P.ESPEN guideline: clinical
nutrition in surgery. Clin Nutr. 2017;36(3):623–50.
6. Ljungqvist O, de Boer HD, Balfour A, Fawcett WJ, Lobo DN, Nelson G, Scott MJ, Wainwright
TW, Demartines N.Opportunities and challenges for the next phase of enhanced recovery after
surgery: a review. JAMA Surg. 2021;156(8):775–84.
7. Gustafsson UO, Scott MJ, Hübner M, Nygren J, Demartines N, Francis N, Rockall TA,
Young-Fadol TW, Hill AG, Soop M, de Boer HD, Urman RD, Chang GJ, Fichera A, Kessler
H, Grass F, Whang EE, Fawcett WJ, Carli F, Lobo DN, Rollins KE, Balfour A, Baldini G,
Riedel B, Ljungqvist O. Guidelines for perioperative care in elective colorectal surgery:
Enhanced Recovery after Surgery (ERAS) Society Recommendations 2018. World J Surg.
2019;43:659–95.
8. Berkel AEM, Bongers BC, Kotte H, Weltevreden P, de Jongh FHC, Eijsvogel MMM, Wymenga
M, Bigirwamungu-Bargeman M, van der Palen J, van Det MJ, van Meeteren NLU, Klaase
JM.Effects of community-based exercise prehabilitation for patients scheduled for colorectal
surgery with high risk for postoperative complications: results of a randomized clinical trial.
Ann Surg. 2022;275(2):e299–306.
9. Carli F, Bousquet-Dion G, Awasthi R, Elsherbini N, Liberman S, Boutros M, Stein B,
Charlebois P, Ghitulescu G, Morin N, Jagoe T, Scheede-Bergdahl C, Minnella EM, Fiore JF
Jr. Effect of multimodal prehabilitation vs postoperative rehabilitation on 30-day postoperative
complications for frail patients undergoing resection of colorectal cancer: a randomized clinical trial. JAMA Surg. 2020;155(3):233–42.
10. Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, Laviano A, Ljungqvist O,
Lobo DN, Martindale RG, Waitzberg D, Bischoff SC, Singer P.ESPEN practical guideline:
clinical nutrition in surgery. Clin Nutr. 2021;40(7):4745–61.
11. Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Hütterer
E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Oldervoll
L, Ravasco P, Solheim TS, Strasser F, de van der Schueren M, Preiser JC, Bischoff SC.ESPEN
practical guideline: clinical nutrition in cancer. Clin Nutr. 2021;40(5):2898–913.
12. Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T,
Baptista G, Barazzoni R, Blaauw R, Coats A, Crivelli A, Evans DC, Gramlich L, FuchsTarlovsky V, Keller H, Llido L, Malone A, Mogensen KM, Morley JE, Muscaritoli M, Nyulasi
I, Pirlich M, Pisprasert V, de van der Schueren MAE, Siltharm S, Singer P, Tappenden K,
Velasco N, Waitzberg D, Yamwong P, Yu J, Van Gossum A, Compher C, GLIM Core Leadership
Committee; GLIM Working Group. GLIM criteria for the diagnosis of malnutrition—a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9.
13. Barazzoni R, Jensen GL, Correia MITD, Gonzalez MC, Higashiguchi T, Shi HP, Bischoff
SC, Boirie Y, Carrasco F, Cruz-Jentoft A, etal. Guidance for assessment of the muscle mass
phenotypic criterion for the Global Leadership Initiative on Malnutrition (GLIM) diagnosis of
malnutrition. Clin Nutr. 2022;41(6):1425–33.
9 Nutritional Care inGastrointestinal Surgery
https://t.me/med1917
14. Caillet P, Liuu E, Raynaud Simon A, Bonnefoy M, Guerin O, Berrut G, Lesourd B, Jeandel C,
Ferry M, Rolland Y, Paillaud E.Association between cachexia, chemotherapy and outcomes in
older cancer patients: a systematic review. Clin Nutr. 2017;36(6):1473–82.
15. Wang P-Y, Chen X-K, Liu Q, Yu Y-K, Xu L, Liu X-B, Zhang R-X, Wang Z-F, Li Y.Highlighting
sarcopenia management for promoting surgical outcomes in esophageal cancers: evidence
from a prospective cohort study. Int J Surg. 2020;83:206–15.
16. Ishida T, Makino T, Yamasaki M, Yamashita K, Tanaka K, Saito T, Yamamoto K, Takahashi
T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Eguchi H, Doki Y.Quantity and quality
of skeletal muscle as an important predictor of clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy. Ann Surg Oncol.
2021;28(12):7185–95.
17. Kuwada K, Kikuchi S, Kuroda S, Yoshida R, Takagi K, Noma K, Nishizaki M, Kagawa S,
Umeda Y, Fujiwara T.Survival impact of postoperative skeletal muscle loss in gastric cancer
patients who underwent gastrectomy. Anticancer Res. 2023;43(1):223–30.
18. Gruber ES, Jomrich G, Tamandl D, Gnant M, Schindl M, Sahora K.Sarcopenia and sarcopenic
obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. PLoS One. 2019;14(5):e0215915.
19. Barazzoni R, Gortan CG.Double burden of malnutrition in persons with obesity. Rev Endocr
Metab Disord. 2020;21(3):307–13.
20. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M, Educational and Clinical Practice
Committee, European Society of Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22(4):415–21.
21. Wischmeyer PE, Carli F, Evans DC, Guilbert S, Kozar R, Pryor A, Thiele RH, Everett S,
Grocott M, Gan TJ, Shaw AD, Thacker JKM, Miller TE, Hedrick TL, McEvoy MD, Mythen
MG, Bergamaschi R, Gupta R, Holubar SD, Senagore AJ, Abola RE, Bennett-Guerrero E,
Kent ML, Feldman LS, Fiore JF Jr, Perioperative Quality Initiative (POQI) 2 Workgroup.
American Society for Enhanced Recovery and Perioperative quality initiative joint consensus
statement on nutrition screening and therapy within a surgical enhanced recovery pathway.
Anesth Analg. 2018;126(6):1883–95.
22. Mayanagi S, Tsubosa Y, Omae K, Niihara M, Uchida T, Tsushima T, Yokota T, Sato H, Naito
T, Yasui H.Negative impact of skeletal muscle wasting after neoadjuvant chemotherapy followed by surgery on survival for patients with thoracic esophageal cancer. Ann Surg Oncol.
2017;24(12):3741–7.
23. Martin L, Gioulbasanis I, Senesse P, Baracos VE. Cancer-associated malnutrition and
CT-dened sarcopenia and myosteatosis are endemic in overweight and obese patients. JPEN
J Parenter Enteral Nutr. 2020;44(2):227–38.
24. Wobith M, Herbst C, Lurz M, Haberzettl D, Fischer M, Weimann A.Evaluation of malnutrition in patients undergoing major abdominal surgery using GLIM criteria and comparing CT
and BIA for muscle mass measurement. Clin Nutr ESPEN. 2022;50:148–54.
25. Gomez-Perez SL, Haus JM, Sheean P, Patel B, Mar W, Chaudhry V, McKeever L, Braunschweig
C. Measuring abdominal circumference and skeletal muscle from a single cross-sectional
computed tomography image: a step-by-step guide for clinicians using National Institutes
of Health ImageJ [Erratum in: JPEN J Parenter Enteral Nutr 2016; 40(5): 742-3.]. JPEN J
Parenter Enteral Nutr. 2016;40(3):308–18.
26. Yin L, Cheng N, Chen P, Zhang M, Li N, Lin X, He X, Wang Y, Xu H, Guo W, Liu J.Association
of Malnutrition, as dened by the PG-SGA, ESPEN 2015, and GLIM criteria, with complications in esophageal cancer patients after esophagectomy. Front Nutr. 2021;8:632546.
27. Kakavas S, Karayiannis D, Bouloubasi Z, Poulia KA, Kompogiorgas S, Konstantinou D,
Vougas V. Global leadership initiative on malnutrition criteria predict pulmonary complications and 90-day mortality after major abdominal surgery in cancer patients. Nutrients.
2020;12(12):1–11.
28. Skeie E, Tangvik RJ, Nymo LS, Harthug S, Lassen K, Viste A.Weight loss and BMI criteria in GLIM’s denition of malnutrition is associated with postoperative complications
153
154
https://t.me/med1917
following abdominal resections—results from a National Quality Registry. Clin Nutr 2020.
2019;39(5):1593–9.
29. Clark AB, Reijnierse EM, Lim WK, Maier AB. Prevalence of malnutrition comparing the
GLIM criteria, ESPEN denition and MST malnutrition risk in geriatric rehabilitation patients:
RESORT.Clin Nutr. 2020;39(11):3504–11.
30. Sanchez-Rodriguez D, Locquet M, Reginster JY, Cavalier E, Bruyère O, Beaudart C.Mortality
in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge
study. J Cachexia Sarcopenia Muscle. 2020;11(5):1200–11.
31. López-Rodríguez-Arias F, Sánchez-Guillén L, Lillo-García C, Aranaz-Ostáriz V, Alcaide MJ,
Soler-Silva Á, Soriano-Irigaray L, Barber X, Arroyo A.Assessment of body composition as
an indicator of early peripheral parenteral nutrition therapy in patients undergoing colorectal
cancer surgery in an enhanced recovery program. Nutrients. 2021;13(9):3245.
32. Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer
JM, Boirie Y, Cruz-Jentoft AJ, Dicker D, Frara S, Frühbeck G, Genton L, Gepner Y, Giustina
A, Gonzalez MC, Han HS, Heymseld SB, Higashiguchi T, Barazzoni R.Denition and diagnostic criteria for Sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts.
2022;15(3):321–35.
33. Ligthart-Melis GC, Weijs PJ, te Boveldt ND, Buskermolen S, Earthman CP, Verheul HM, de
Lange-de Klerk ES, van Weyenberg SJ, van der Peet DL.Dietician-delivered intensive nutritional support is associated with a decrease in severe postoperative complications after surgery
in patients with esophageal cancer. Dis Esophagus. 2013;26(6):587–93.
34. Wobith M, Weimann A.Postoperative nutrition management—who needs what? Visc Med.
2022;38(5):354–62.
35. Slim K, Badon F, Vacheron CH, Occean BV, Dziri C, Chambrier C.Umbrella review of the efcacy of perioperative immunonutrition in visceral surgery. Clin Nutr ESPEN. 2022;48:99–108.
36. Adiamah A, Skořepa P, Weimann A, Lobo DN.The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer. Ann Surg.
2019;270(2):247–56.
37. Cao Y, Han D, Yang S, Shi Y, Zhao S, Jin Q, Li J, Li C, Zhang Y, Shen W, He J, Wang M, Ji
G, Li Z, He Y, Chen Q, Wei W, Chen C, Gong X, Wang J, Tan L, Wang H, Li H.Effects of
pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant
chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, preoperative immunonutrition therapy). BMC Cancer. 2022;22(1):650.
38. Moya P, Soriano-Irigaray L, Ramirez JM, Garcea A, Blasco O, Blanco FJ, Brugiotti C, Miranda
E, Arroyo A. Perioperative standard oral nutrition supplements versus immunonutrition in
patients undergoing colorectal resection in an enhanced recovery (ERAS) protocol: a multicenter randomized clinical trial (SONVI study). Medicine (Baltimore). 2016;95(21):e3704.
39. Ligthart-Melis GC, Luiking YC, Kakourou A, Cederholm T, Maier AB, de van der Schueren
MAE.Frailty, sarcopenia, and malnutrition frequently (co-)occur in hospitalized older adults:
a systematic review and meta-analysis. J Am Med Dir Assoc. 2020;21(9):1216–28.
40. Davies SJ, West MA, Rahman SA, Underwood TJ, Marino LV.Oesophageal cancer: the effect
of early nutrition support on clinical outcomes. Clin Nutr ESPEN. 2021;42:117–23.
41. McIsaac DI, Gill M, Boland L, Hutton B, Branje K, Shaw J, Grudzinski AL, Barone N, Gillis
C, Akhtar S, Atkins M, Aucoin S, Auer R, Basualdo-Hammond C, et al. Prehabilitation in
adult patients undergoing surgery: an umbrella review of systematic reviews. Br J Anaesth.
2022;128(2):244–57.
42. Molenaar CJL, Minnella EM, Coca-Martinez M, Ten Cate DWG, Regis M, Awasthi R, MartínezPalli G, López-Baamonde M, Sebio-Garcia R, Feo CV, van Rooijen SJ, Schreinemakers JMJ,
Bojesen RD, Gögenur I, van den Heuvel ER, Carli F, Slooter GD, PREHAB Study Group.
Effect of multimodal prehabilitation on reducing postoperative complications and enhancing
functional capacity following colorectal cancer surgery: the PREHAB randomized clinical
trial. JAMA Surg. 2023;58(6):572–81.
43. Daniels SL, Lee MJ, George J, Kerr K, Moug S, Wilson TR, Brown SR, Wyld L.Prehabilitation
in elective abdominal cancer surgery in older patients: systematic review and meta-analysis.
BJS Open. 2020;4(6):1022–41.
M. Wobith and A. Weimann
9 Nutritional Care inGastrointestinal Surgery
https://t.me/med1917
44. Gillis C, Buhler K, Bresee L, Carli F, Gramlich L, Culos-Reed N, Sajobi TT, Fenton
TR.Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients
who undergo colorectal surgery: a systematic review and meta-analysis. Gastroenterology.
2018;155(2):391–410.e4.
45. Hughes MJ, Hackney RJ, Lamb PJ, Wigmore SJ, Christopher Deans DA, Skipworth
RJE.Prehabilitation before major abdominal surgery: a systematic review and meta-analysis.
World J Surg. 2019;43(7):1661–8.
46. Chowdhury AH, Adiamah A, Kushairi A, Varadhan KK, Krznaric Z, Kulkarni AD, Neal KR,
Lobo DN. Perioperative probiotics or synbiotics in adults undergoing elective abdominal
surgery: a systematic review and meta-analysis of randomized controlled trials. Ann Surg.
2020;271(6):1036–47.
47. Martin L, Gillis C, Atkins M, Gillam M, Sheppard C, Buhler S, Hammond CB, Nelson G,
Gramlich L.Implementation of an enhanced recovery after surgery program can change nutrition care practice: a multicenter experience in elective colorectal surgery. JPEN J Parenter
Enteral Nutr. 2019;43(2):206–19.
48. Berkelmans GHK, Fransen LFC, Dolmans-Zwartjes ACP, Kouwenhoven EA, van Det MJ,
Nilsson M, Nieuwenhuijzen GAP, Luyer MDP.Direct oral feeding following minimally invasive esophagectomy (NUTRIENT II trial): an international, multicenter, open-label randomized controlled trial. Ann Surg. 2020;271(1):41–7.
49. Zhang B, Najarali Z, Ruo L, Alhusaini A, Solis N, Valencia M, Sanchez MIP, Serrano PE.Effect
of perioperative nutritional supplementation on postoperative complications- systematic review
and meta-analysis. J Gastrointest Surg. 2019;23(8):1682–93.
50. Baker M, Halliday V, Williams RN, Bowrey DJ.A systematic review of the nutritional consequences of esophagectomy. Clin Nutr. 2016;35(5):987–94.
51. Wobith M, Wehle L, Haberzettl D, Acikgöz A, Weimann A.Needle catheter jejunostomy in
patients undergoing surgery for upper gastrointestinal and pancreato-biliary cancer—impact
on nutritional and clinical outcome in the early and late postoperative period. Nutrients.
2020;12:2564.
52. Koterazawa Y, Oshikiri T, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S,
Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y.Severe weight loss after minimally
invasive oesophagectomy is associated with poor survival in patients with oesophageal cancer
at 5 years. BMC Gastroenterol. 2020;20(1):1–9.
53. Aoyama T, Yoshikawa T, Maezawa Y, Kano K, Numata M, Hara K, Komori K, Yamada T,
Hayashi T, Sato T, Tamagawa H, Yukawa N, Rino Y, Masuda M, Ogata T, Cho H, Oshima
T.The postoperative lean body mass loss at one month leads to a poor survival in patients with
locally advanced gastric cancer. J Cancer. 2019;10(11):2450–6.
54. Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T,
Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T.Loss of lean body mass as an independent
risk factor for continuation of s-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol.
2015;22(8):2560–6.
55. Weijs TJ, van Eden HWJ, Ruurda JP, Luyer MP, Stenhagen E, Nieuwenhuijzen GAP, van
Hilgersberg R.Routine jejunostomy tube feeding following esophagectomy. J Thorac Dis.
2017;9:S851–60.
56. Zhuang W, Wu H, Liu H, Huang S, Wu Y, Deng C, Tian D, Zhou Z, Shi R, Chen G, Piessen
G, Khaitan PG, Koyanagi K, Ozawa S, Qiao G.Utility of feeding jejunostomy in patients
with esophageal cancer undergoing esophagectomy with a high risk of anastomotic leakage. J
Gastrointest Oncol. 2021;12(2):433–45.
57. Li HN, Chen Y, Dai L, Wang Y-Y, Chen M-W, Mei L-X.A meta-analysis of jejunostomy versus
nasoenteral tube for enteral nutrition following esophagectomy. J Surg Res. 2021;264:553–61.
58. Holmén A, Hayami M, Szabo E, Rouvelas I, Agustsson T, Klevebro F.Nutritional jejunostomy
in esophagectomy for cancer, a national register-based cohort study of associations with postoperative outcomes and survival. Langenbecks Arch Surg. 2020;406(5):1415–23.
59. Shen X, Zhuo Z-G, Li G, Alai G-H, Song T-N, Xu Z-J, Yao P, Lin Y-D.Is the routine placement
of a feeding jejunostomy during esophagectomy worthwhile? A systematic review and metaanalysis. Ann Palliat Med. 2021;10:4232–41.
155
156
https://t.me/med1917
60. Durán-Poveda M, Bonavina L, Reith B, Caruso R, Klek S, Senkal M.Nutrition practices with
a focus on parenteral nutrition in the context of enhanced recovery programs: an exploratory
survey of gastrointestinal surgeons. Clin Nutr ESPEN. 2022;50:138–47.
61. Gao X, Liu Y, Zhang L, Zhou D, Tian F, Gao T, Tian H, Hu H, Gong F, Guo D, Zhou J, Gu Y,
Lian B, Xue Z, Jia Z, Chen Z, Wang Y, Jin G, Wang K, Zhou Y, Chi Q, Yang H, Li M, Yu J,
Qin H, Tang Y, Wu X, Li G, Li N, Li J, Pichard C, Wang X.Effect of early vs late supplemental parenteral nutrition in patients undergoing abdominal surgery: a randomized clinical trial.
JAMA Surg. 2022;157(5):384–93.
62. Pradelli L, Mayer K, Klek S, Omar Alsaleh AJ, Clark RAC, Rosenthal MD, Heller AR,
Muscaritoli M. ω-3 Fatty-acid enriched parenteral nutrition in hospitalized patients: systematic review with meta-analysis and trial sequential analysis. JPEN J Parenter Enteral Nutr.
2020;44(1):44–57.
63. Ziegler TR, May AK, Hebbar G, Easley KA, Grifth DP, Dave N, Collier BR, Cotsonis GA,
Hao L, Leong T, Manatunga AK, Rosenberg ES, Jones DP, Martin GS, Jensen GL, Sax HC,
Kudsk KA, Galloway JR, Blumberg HM, Evans ME, Wischmeyer PE.Efcacy and safety
of glutamine-supplemented parenteral nutrition in surgical ICU patients: an American multicenter randomized controlled trial. Ann Surg. 2016;263(4):646–55.
64. Elke G, Hartl WH, Kreymann KG, Adolph M, Felbinger TW, Graf T, de Heer G, Heller AR,
Kampa U, Mayer K, Muhl E, Niemann B, Rümelin A, Steiner S, Stoppe C, Weimann A,
Bischoff SC.Clinical nutrition in critical care medicine—guideline of the German Society for
Nutritional Medicine (DGEM). Clin Nutr ESPEN. 2019;33:220–75.
65. Ridley EJ, Parke RL, Davies AR, Bailey M, Hodgson C, Deane AM, McGuinness S, Cooper
DJ.What happens to nutrition intake in the post-intensive care unit hospitalization period? An
observational cohort study in critically ill adults. JPEN J Parenter Enteral Nutr. 2019;43:88–95.
66. Heneghan HM, Zaborowski A, Fanning M, McHugh A, Doyle S, Moore J, Ravi N, Reynolds
JV.Prospective study of malabsorption and malnutrition after esophageal and gastric cancer
surgery. Ann Surg. 2015;262(5):803–7.
67. Wobith M, Weimann A.Oral nutritional supplements and enteral nutrition in patients with
gastrointestinal surgery. Nutrients. 2021;13(8):2655.
68. Meng Q, Tan S, Jiang Y, Han J, Xi Q, Zhuang Q, Wu G.Post-discharge oral nutritional supplements with dietary advice in patients at nutritional risk after surgery for gastric cancer: a randomized clinical trial. Clin Nutr. 2021;40:40–6.
69. Chen X, Zhao G, Zhu L.Home enteral nutrition for postoperative elderly patients with esophageal cancer. Ann Palliat Med. 2021;10(1):278–84.
70. Xueting H, Li L, Meng Y, Yuqing C, Yutong H, Lihong Q, June Z.Home enteral nutrition and
oral nutritional supplements in postoperative patients with upper gastrointestinal malignancy:
a systematic review and meta-analysis. Clin Nutr. 2020;40(5):3082–93.
71. Liu F, Pan X, Zhao S, Ren R, Chang G, Mao Y.Effect of home enteral nutritional support
compared with normal oral diet in postoperative subjects with upper gastrointestinal cancer
resection: a meta-analysis. Front Surg. 2022;9:844475.
72. Komatsu S, Konishi T, Matsubara D, Soga K, Shimomura K, Ikeda J, Taniguchi F, Iwase H,
Kubota T, Shioaki Y, Otsuji E. Night home enteral nutrition as a novel enforced and physiologically effective nutrition therapy following total gastrectomy for gastric cancer. Sci Rep.
2022;12(1):14922.
73. Miyazaki Y, Omori T, Fujitani K, Fujita J, Kawabata R, Imamura H, Okada K, Moon JH, Hirao
M, Matsuyama J, Saito T, Takahashi T, Kurokawa Y, Yamasaki M, Takiguchi S, Mori M, Doki
Y, Osaka University Clinical Research Group for Gastroenterological Study. Oral nutritional
supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3,
multicenter, open-label randomized controlled trial. Gastric Cancer. 2021;24(5):1150–9.
74. Nose Y, Yamashita K, Takeoka T, Momose K, Saito T, Tanaka K, Yamamoto K, Makino T,
Takahashi T, Kurokawa Y, Yamasaki M, Shiraishi O, Miyata H, Yasuda T, Yano M, Eguchi H,
Doki Y. Perioperative ghrelin administration attenuates postoperative skeletal muscle loss in
M. Wobith and A. Weimann
9 Nutritional Care inGastrointestinal Surgery
https://t.me/med1917
patients undergoing esophagectomy for esophageal cancer: secondary analysis of a randomized controlled trial. Ann Surg Oncol. 2022;29(6):3604–12.
75. Ford KL, Prado CM, Weimann A, Schuetz P, Lobo DN. Unresolved issues in perioperative
nutrition: a narrative review. Clin Nutr. 2022;41:1578–90.
157
Part III
https://t.me/med1917
Surgical Specialties
Chapter 10
https://t.me/med1917
Risk Reduction inDiabetic Patients
Undergoing Orthopaedic Surgery
MichaelS.Pinzur
Introduction
Most experts herald the 1999 publication from the Institute of Medicine, “To Err is
Human”, as the beginning of the “Patient Safety Movement” [1]. This seminal report
estimated that up to 98,000 deaths occurred yearly in the United States due to preventable errors occurring during the delivery of health care. Avoiding error became
the focus during the early phase of this paradigm shift. Early adopters borrowed on
the concepts of entropy that we learned in high school physics, appreciating that a
system left to its own devices, would revert to disorder. It was felt that this systemic
disorder was responsible for the errors that led to patient harm. Patient care pathways and clinical algorithms evolved as the methodology to standardize clinical
care and counteract these error-producing forces. They borrowed the principles of
decision support from the business world to develop clinical systems that were
designed to lessen the risk for deviation and error.
The by-product of this thinking was likely a strong motivating force that led to
the development of Hospitalist-Orthopaedic co-management programs. Introducing
internal medicine principles led to the development of clinical algorithms designed
to not only decrease the risk for error, but also decrease the risks of co-morbidity
disease-impact on clinical care. The nal step leading to the most forward thinking
delivery of health care was the asking the question when performing elective surgery … If we make sick patients less sick, will their clinical outcomes be improved?
This evolution in thinking allowed the Patient Safety Movement to evolve from the
simple avoidance of treatment errors, to the current approach that medically
M. S. Pinzur (*)
Department of Orthopaedic Surgery and Rehabilitation, Loyola University Medical Center,
Maywood, IL, USA
e-mail: mpinzu1@lumc.edu
Switzerland AG 2024
J. Faintuch, S. Faintuch (eds.), Recent Strategies in High Risk Surgery,
https://doi.org/10.1007/978-3-031-56270-9_10
161© The Author(s), under exclusive license to Springer Nature
162
https://t.me/med1917
M. S. Pinzur
optimizes patients’ co-morbidities, thus allowing sick patients to take advantage of
modern clinical innovations at a reasonable risk tolerance.
The United States Centers for Disease Control currently estimates that there
are over 30 million diabetes in the United States, a number approaching 10% of
our population, with an estimated over 80 million additional individuals over 18
years of age being pre-diabetic [2]. This objective of this chapter to provide physicians the clinical tools to employ the modern methods of medical optimization for
complex diabetic patients undergoing emergent, urgent and elective Orthopaedic
Surgery [3].
Diabetic Organ System Disease
The primary initiator of diabetic organ system disease is the presence of elevated
blood sugar over time. Elevated blood sugar binds with hemoglobin within red
blood cells to form glycosylated hemoglobin, which is clinically measured as
hemoglobin A1C.This glycosylated hemoglobin leads to a release of free radicals, which damages the basement membrane of all vessels in the arterial tree,
leading to a similar level of disease expression in all key organ systems [4, 5]. We
have long viewed the presence of peripheral neuropathy, as measured by insensitivity to the Semmes- Weinstein 5.07 monolament, as an important risk factor in
diabetics (Fig.10.1). Instead of viewing insensitivity to the monolament as a risk
Fig. 10.1 Semmes-Weinstein 5.07 monolament. This monolament imparts 10 g of pressure to
the tuft of the hallux. When patients cannot, perceive this amount of pressure, they exhibit a level
of sensory peripheral neuropathy that is associated with other diabetic organ system disease. Long
thought of as a risk factor for associated organ system disease, this level of peripheral neuropathy
should be considered as a disease marker, as patients with peripheral neuropathy also have a level
of cardiac, pulmonary, renal disease and osteoporosis
10 Risk Reduction inDiabetic Patients Undergoing Orthopaedic Surgery
https://t.me/med1917
factor, we should view the presence of peripheral neuropathy as a measure of
disease expression.
When caring for patients, we view the serum level of hemoglobin A1C, as a
measure of estimated serum glucose levels over the past 3 months. We use the measurement of serum glucose as a temporal measure of real-time blood sugar. It is this
measurement that allows the poorly controlled diabetic to develop both the acute
and chronic consequences of life-threatening ketoacidosis. Management of serum
glucose will be expanded when we discuss the hard stops of care for diabetic
patients.
163
Hospitalist Co-management
The increasing complexities associated with the delivery of complex medical
care led to the development of the Hospitalist, as a medical specialty. First
described by Wachter in 1996, the care of hospitalized medical patients has been
assumed by physicians who could focus on inpatient medical care, without the
associated stresses of an outpatient medical practice [6, 7]. Early adopters to the
Hospitalist patient care model expanded this concept to develop co-management
partnerships with Orthopaedic and other surgical colleagues. Patients could
then have the added advantage of medical expertise when clinical care could be
managed as a team effort. While these programs were not initially able to
improve the metrics of health care, experience has led to improved clinical outcomes, decreased rates of complications and hospital re-admissions, and substantial cost savings [8–11].
Most musculoskeletal care is currently provided in the ambulatory setting. Total
hip and knee arthroplasty is increasingly being performed on healthy individuals
without hospital admission. Therefore, virtually all patients undergoing inpatient
urgent or elective Orthopaedic surgery have sufcient medical co-morbidities to
warrant the routine utilization of a Hospitalist-Orthopaedic co-management patient
care model [12].
The Hard Stops
There are four medical co-morbidities that have clearly been associated with
increased rates of death, poor clinical outcomes, surgical site infections, perioperative complications, hospital re-admission and impaired metrics of health care [3,
13]. Glucose management in both diabetics and non-diabetics, cardio-pulmonary
function, anemia and hypertension, are the critical medical co-morbidities that must
be addressed, regardless of the nature of surgery. We call these four medical comorbidities hard stops, as they must be addressed when both performing emergent
or urgent surgery, and have the potential to be optimized prior to elective surgery.
Соседние файлы в папке Библиотека им академика М.И. Перельмана